OVERALL SURVIVAL WITH CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, THERAPY-RELATED ACUTE MYELOID LEUKEMIA: SUBGROUP ANALYSIS OF A PHASE 3 STUDY
Publication
, Conference
Lancet, JE; Rizzieri, D; Schiller, GJ; Stuart, RK; Kolitz, JE; Solomon, SR; Newell, LF; Erba, H; Uy, GL; Ryan, R; Chiarella, M; Louie, AC; Cortes, JE
Published in: HAEMATOLOGICA
June 26, 2017
Duke Scholars
Published In
HAEMATOLOGICA
ISSN
0390-6078
Publication Date
June 26, 2017
Volume
102
Start / End Page
214 / 215
Location
Madrid, SPAIN
Publisher
FERRATA STORTI FOUNDATION
Conference Name
22nd Congress of the European-Hematology-Association
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lancet, J. E., Rizzieri, D., Schiller, G. J., Stuart, R. K., Kolitz, J. E., Solomon, S. R., … Cortes, J. E. (2017). OVERALL SURVIVAL WITH CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, THERAPY-RELATED ACUTE MYELOID LEUKEMIA: SUBGROUP ANALYSIS OF A PHASE 3 STUDY. In HAEMATOLOGICA (Vol. 102, pp. 214–215). Madrid, SPAIN: FERRATA STORTI FOUNDATION.
Lancet, J. E., D. Rizzieri, G. J. Schiller, R. K. Stuart, J. E. Kolitz, S. R. Solomon, L. F. Newell, et al. “OVERALL SURVIVAL WITH CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, THERAPY-RELATED ACUTE MYELOID LEUKEMIA: SUBGROUP ANALYSIS OF A PHASE 3 STUDY.” In HAEMATOLOGICA, 102:214–15. FERRATA STORTI FOUNDATION, 2017.
Lancet JE, Rizzieri D, Schiller GJ, Stuart RK, Kolitz JE, Solomon SR, et al. OVERALL SURVIVAL WITH CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, THERAPY-RELATED ACUTE MYELOID LEUKEMIA: SUBGROUP ANALYSIS OF A PHASE 3 STUDY. In: HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2017. p. 214–5.
Lancet, J. E., et al. “OVERALL SURVIVAL WITH CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, THERAPY-RELATED ACUTE MYELOID LEUKEMIA: SUBGROUP ANALYSIS OF A PHASE 3 STUDY.” HAEMATOLOGICA, vol. 102, FERRATA STORTI FOUNDATION, 2017, pp. 214–15.
Lancet JE, Rizzieri D, Schiller GJ, Stuart RK, Kolitz JE, Solomon SR, Newell LF, Erba H, Uy GL, Ryan R, Chiarella M, Louie AC, Cortes JE. OVERALL SURVIVAL WITH CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, THERAPY-RELATED ACUTE MYELOID LEUKEMIA: SUBGROUP ANALYSIS OF A PHASE 3 STUDY. HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2017. p. 214–215.
Published In
HAEMATOLOGICA
ISSN
0390-6078
Publication Date
June 26, 2017
Volume
102
Start / End Page
214 / 215
Location
Madrid, SPAIN
Publisher
FERRATA STORTI FOUNDATION
Conference Name
22nd Congress of the European-Hematology-Association
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology